Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γ Activation

被引:183
作者
Jacob, Asha [1 ,2 ,3 ]
Wu, Rongqian [1 ,2 ,3 ]
Zhou, Mian [1 ,2 ,3 ]
Wang, Ping [1 ,2 ,3 ]
机构
[1] N Shore Univ Hosp, Div Surg Res, Manhasset, NY 11030 USA
[2] Long Isl Jewish Med Ctr, Manhasset, NY 11030 USA
[3] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA
关键词
D O I
10.1155/2007/89369
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Curcumin, the phytochemical component in turmeric, is used as a dietary spice and a topical ointment for the treatment of inflammation in India for centuries. Curcumin (diferuloylmethane) is relatively insoluble in water, but dissolves in acetone, dimethylsulphoxide, and ethanol. Commercial grade curcumin contains 10-20% curcuminoids, desmethoxycurcumin, and bis-desmethoxycurcumin and they are as effective as pure curcumin. Based on a number of clinical studies in carcinogenesis, a daily oral dose of 3.6 g curcumin has been efficacious for colorectal cancer and advocates its advancement into Phase II clinical studies. In addition to the anticancer effects, curcumin has been effective against a variety of disease conditions in both in vitro and in vivo preclinical studies. The present review highlights the importance of curcumin as an anti-inflammatory agent and suggests that the beneficial effect of curcumin is mediated by the upregulation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation. Copyright (c) 2007 Asha Jacob et al.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
    Shoba, G
    Joy, D
    Joseph, T
    Majeed, M
    Rajendran, R
    Srinivas, PSSR
    [J]. PLANTA MEDICA, 1998, 64 (04) : 353 - 356
  • [42] The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ
    Siddiqui, Aqeel M.
    Cui, Xiaoxuan
    Wu, Rongqian
    Dong, Weifeng
    Zhou, Mian
    Hu, Maowen
    Simms, H. Hank
    Wang, Ping
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (07) : 1874 - 1882
  • [43] Sidhu Gurmel S., 1998, Wound Repair and Regeneration, V6, P167, DOI 10.1046/j.1524-475X.1998.60211.x
  • [44] PHARMACOLOGY OF DIFERULOYL METHANE (CURCUMIN), A NONSTEROIDAL ANTIINFLAMMATORY AGENT
    SRIMAL, RC
    DHAWAN, BN
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (06) : 447 - 452
  • [45] Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity
    Taneja, R
    Parodo, J
    Jia, SH
    Kapus, A
    Rotstein, OD
    Marshall, JC
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (07) : 1460 - 1469
  • [46] Thaloor D, 1998, CELL GROWTH DIFFER, V9, P305
  • [47] TODA S, 1985, CHEM PHARM BULL, V33, P1725
  • [48] WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86
  • [49] Stability of curcumin in buffer solutions and characterization of its degradation products
    Wang, YJ
    Pan, MH
    Cheng, AL
    Lin, LI
    Ho, YS
    Hsieh, CY
    Lin, JK
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (12) : 1867 - 1876
  • [50] Peroxisome proliferator activator receptor-γ ligands, 15-deoxy-Δ12,14-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways
    Zingarelli, B
    Sheehan, M
    Hake, PW
    O'Connor, M
    Denenberg, A
    Cook, JA
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (12) : 6827 - 6837